Fingerprint
Dive into the research topics of 'A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study
on behalf of the HESTIA1 Investigators
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations